Dynamics of recovery of cognitive deficit in patients in the early recovery period of ischemic stroke

Close metadata

OBJECTIVE

Study of the effectiveness of the use of the drug Ampasse in the process of complex rehabilitation in patients in the early recovery period of ischemic stroke at the second (stationary) stage.

MATERIAL AND METHODS

The study included 60 patients, 28 women and 32 men, aged 43 to 76 years (mean — 58.4±9.1 years), in the recovery period after suffering a stroke in the period from 1 to 12 months (on average — 4.7±3.5 months). All patients received complex rehabilitation, patients of the 1st group received additional intravenous injections of the drug Ampasse 25 mg (5.0 ml), 15 injections. Patients of the 2nd group (n 0) did not receive Ampasse. To assess cognitive functions, the following tests were used: the Montreal Cognitive Assessment Scale (MoCA), Stroop’s test, subtest 9 of the Wechsler test, Koos cubes (CC), the severity of anxiety and depression was assessed, and motor recovery was assessed by the hand motor activity test (ARAT). The assessment was carried out before the start of treatment and on the 21st day.

RESULTS

There was a statistically significant increase in the score on the MoCA scale, in patients of the 1st group by an average of 2 points, in the 2nd group there was no significant dynamics, a statistically significant difference was found in the proportion of patients who had an increase in the MoCA index after the course of treatment in the 1st group. compared with the 2nd (χ² — 22.528, p<0.001). Decreased the level of rigidity according to the Stroop test in patients of the 1st group compared with the 2nd (χ²— 8.297, p=0.004). The number of patients who showed positive dynamics in the Koos cubes test in the 1st group was statistically significantly higher (χ²— 4.344, p=0.038). A statistically significant decrease in the level of depression was revealed in patients of the 1st group. The number of patients with improved motor function of the hand was greater in the 1st group of MG (χ² — 4.286, p<0.039).

CONCLUSION

In patients in complex therapy receiving intravenous administration of the drug Ampasse at a dose of 25 mg (5.0 ml) 15 administrations, a statistically significant improvement in cognitive functions was revealed according to MoCA tests, Stroop test, Koos Cubes, when compared with the comparison group. The use of Ampasse increased the effectiveness of cognitive and motor rehabilitation in patients with post-stroke disorders.

Keywords:

acute ischemic stroke

rehabilitation

rehabilitation treatment

Ampasse

Authors:

Kotov S.V.

Vladimirsky Moscow Regional Research Clinical Institute

SPIN RSCI: 1798-0837
Scopus AuthorID: 7005990035
ResearcherID: E-4451-2017
ORCID: 0000-0002-8706-7317

Borisova V.A.

Vladimirsky Moscow Regional Research Clinical Institute

Slyunkova E.V.

Vladimirsky Moscow Regional Research Clinical Institute

Isakova E.V.

Vladimirsky Moscow Regional Clinical Research Institute

Kiselev A.V.

Semenov Institute of Chemical Physics

Kotov A.S.

Vladimirsky Moscow Regional Research Clinical Institute

Received:

15.10.2021

Accepted:

13.11.2021

List of references:

GBD 2016 Neurology Collaborators. Global, regional, and national burden of neurological disorders, 1990—2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18(5):459-480. https://doi.org/10.1016/S1474-4422(18)30499-X
Sun JH, Tan L, Yu JT. Post-stroke cognitive impairment: epidemiology, mechanisms and management. Ann Transl Med. 2014;2(8):80-99. https://doi.org/10.3978/j.issn.2305-5839.2014.08.05
Kalaria RN, Akinyemi R, Ihara M. Stroke injury, cognitive impairment and vascular dementia. Biochim Biophys Acta. 2016;1862(5):915-925. https://doi.org/10.1016/j.bbadis.2016.01.015
Pendlebury ST, Rothwell PM; Oxford Vascular Study. Incidence and prevalence of dementia associated with transient ischaemic attack and stroke: analysis of the population-based Oxford Vascular Study. Lancet Neurol. 2019;18(3):248-258. https://doi.org/10.1016/S1474-4422(18)30442-3
Yao YY, Wei ZJ, Zhang YC, et al. Functional Disability After Ischemic Stroke: A Community-Based Cross-Sectional Study in Shanghai, China. Front Neurol. 2021;12:649088. https://doi.org/10.3389/fneur.2021.649088
Jokinen H, Melkas S, Ylikoski R, et al. Post-stroke cognitive impairment is common even after successful clinical recovery. Eur J Neurol. 2015;22(9):1288-1294. https://doi.org/10.1111/ene.12743
Gorelick PB, Scuteri A, Black SE, et al. American Heart Association Stroke Council, Council on Epidemiology and Prevention, Council on Cardiovascular Nursing, Council on Cardiovascular Radiology and Intervention, and Council on Cardiovascular Surgery and Anesthesia. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke. 2011;42(9):2672-2713. https://doi.org/10.1161/STR.0b013e3182299496
Zhan M, Sun L, Liu J, et al. EGb in the Treatment for Patients with VCI: A Systematic Review and Meta-Analysis. Oxid Med Cell Longev. 2021;2021:8787684. https://doi.org/10.1155/2021/8787684
Battle CE, Abdul-Rahim AH, Shenkin SD, et al.Cholinesterase inhibitors for vascular dementia and other vascular cognitive impairments: a network meta-analysis. Cochrane Database Syst Rev. 2021;2(2):CD013306. https://doi.org/10.1002/14651858.CD013306.pub2
McShane R, Westby MJ, Roberts E, et al. Memantine for dementia. Cochrane Database Syst Rev. 2019;3(3):CD003154. https://doi.org/10.1002/14651858.CD003154.pub6
Lewerenz J, Maher P. Chronic Glutamate Toxicity in Neurodegenerative Diseases-What is the Evidence? Front Neurosci. 2015;9:469. https://doi.org/10.3389/fnins.2015.00469
Granzotto A, Canzoniero LMT, Sensi SL. A Neurotoxic Ménage-à-trois: Glutamate, Calcium, and Zinc in the Excitotoxic Cascade. Front Mol Neurosci. 2020;13:600089. https://doi.org/10.3389/fnmol.2020.600089
Song X, Jensen MØ, Jogini V, et al. Mechanism of NMDA receptor channel block by MK-801 and memantine. Nature. 2018;556(7702):515-519. https://doi.org/10.1038/s41586-018-0039-9
Kiselev AV, Vostrikova EV, Kalinina TS, Stovbun SV. Randomized double-blind placebo-controlled study of the efficacy and safety of ampasse in the treatment of chronic cerebral ischemia. Journal of Neurology and Psychiatry named after S.S. Korsakov. 2019;119(4):21-25. (In Russ.). https://doi.org/10.17116/jnevro201911904121
Skoromets AA, Kotov SV, Voronkov PB, et at. Efficacy and safety of ampasse therapy: results of a randomized, double-blind, placebo-controlled trial in patients with chronic cerebrovascular accident. Journal of Neurology and Psychiatry named after C.C. Korsakov. 2021;121(5):26-32. (In Russ.). https://doi.org/10.17116/jnevro202112105126
Shi D, Chen X, Li Z. Diagnostic test accuracy of the Montreal Cognitive Assessment in the detection of post-stroke cognitive impairment under different stages and cutoffs: a systematic review and meta-analysis. Neurol Sci. 2018;39(4):705-716. https://doi.org/10.1007/s10072-018-3254-0
Periáñez JA, Lubrini G, García-Gutiérrez A, et al. Construct Validity of the Stroop Color-Word Test: Influence of Speed of Visual Search, Verbal Fluency, Working Memory, Cognitive Flexibility, and Conflict Monitoring. Arch Clin Neuropsychol. 2021;36(1):99-111. https://doi.org/10.1093/arclin/acaa034
Wisdom NM, Mignogna J, Collins RL. Variability in Wechsler Adult Intelligence Scale-IV subtest performance across age. Arch Clin Neuropsychol. 2012;27(4):389-397. https://doi.org/10.1093/arclin/acs041
Clinciu AI. A New Block Design Test: An Exploratory Study. Procedia — Social and Behavioral Sciences. 2015;187:369-373. https://doi.org/10.1016/j.sbspro.2015.03.069
Herrmann C. International experiences with the Hospital Anxiety and Depression Scale-a review of validation data and clinical results. J Psychosom Res. 1997;42(1):17-41. https://doi.org/10.1016/s0022-3999(96)00216-4
Ilut S, Stan A, Blesneag A, Vacaras V, et al. Factors that influence the severity of post-stroke depression. J Med Life. 2017;10(3):167-171.
Lyle RC. A performance test for assessment of upper limb function in physical rehabilitation treatment and research. Int J Rehabil Res. 1981;4(4):483-492. https://doi.org/10.1097/00004356-198112000-00001
Narasimhalu K, Ang S, De Silva DA, et al. Severity of CIND and MCI predict incidence of dementia in an ischemic stroke cohort. Neurology. 2009;73(22):1866-1872. https://doi.org/10.1212/WNL.0b013e3181c3fcb7
Marei HE, Hasan A, Rizzi R, et al. Potential of Stem Cell-Based Therapy for Ischemic Stroke. Front Neurol. 2018;9:34-39. https://doi.org/10.3389/fneur.2018.00034
Szelenberger R, Kostka J, Saluk-Bijak J, Miller E. Pharmacological Interventions and Rehabilitation Approach for Enhancing Brain Self-repair and Stroke Recovery. Curr Neuropharmacol. 2020;18(1):51-64. https://doi.org/10.2174/1570159X17666190726104139
Coleman ER, Moudgal R, Lang K, et al. Early Rehabilitation After Stroke: a Narrative Review. Curr Atheroscler Rep. 2017;19(12):59-64. https://doi.org/10.1007/s11883-017-0686-6
Farooq MU, Min J, Goshgarian C, Gorelick PB. Pharmacotherapy for Vascular Cognitive Impairment. CNS Drugs. 2017;31(9):759-776. https://doi.org/10.1007/s40263-017-0459-3

Close metadata